In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR -/-ApoB100/100 mice
Research output: Contribution to journal › Article
Macro- and microvascular complications of diabetes: Studies on NFAT (Nuclear Factor of Activated T-cells) as a novel target for the treatment of atherosclerosis and vascular dysfunction in diabetes.Fabiana Blanco, 2018, Lund: Lund University: Faculty of Medicine. 125 p.
Research output: Thesis › Doctoral Thesis (compilation)